← FDA Drug Approvals (Drugs@FDA)
FLUTICASONE PROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON · Approved 2025-08-15
Drug application
- FDA Application #
ANDA219060- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUTICASONE PROPIONATE
- Generic name
- FLUTICASONE PROPIONATE NASAL
- Active ingredients
- FLUTICASONE PROPIONATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Over-the-counter
- Sponsor
- RUBICON
- Manufacturer
- Advagen Pharma Ltd.
- First approval
- 2025-08-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown